(Q48642231)

English

Secondary prevention of stroke in patients with atrial fibrillation: factors influencing the prescription of oral anticoagulation at discharge

scientific article published on 15 February 2006

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

Secondary prevention of stroke in patients with atrial fibrillation: factors influencing the prescription of oral anticoagulation at discharge (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

atrial fibrillation

0 references

anticoagulation

1 reference

based on heuristic

inferred from title

Dominique Deplanque

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

5

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

Lucilla Parnetti

3

object named as

Lucilla Parnetti

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

author name string

Didier Leys

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

Reinhold Schmidt

4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

Jacques de Reuck

6

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

Jean-Louis Mas

7

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

Virgilio Gallai

8

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

SAFE II Investigators

9

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

publication date

15 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

Cerebrovascular Diseases

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

21

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

5-6

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

372-379

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

https://api.crossref.org/works/10.1159%2F000091546

21 January 2018

Prevention. European Stroke Initiative

1 reference

https://api.crossref.org/works/10.1159%2F000091546

21 January 2018

Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients

1 reference

https://api.crossref.org/works/10.1159%2F000091546

21 January 2018

Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study

1 reference

https://api.crossref.org/works/10.1159%2F000091546

21 January 2018

Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals

1 reference

https://api.crossref.org/works/10.1159%2F000091546

21 January 2018

Secondary stroke prevention in atrial fibrillation: lessons from clinical practice.

1 reference

https://api.crossref.org/works/10.1159%2F000091546

21 January 2018

Silent infarcts in patients with ischemic stroke are related to age and size of the left atrium

1 reference

https://api.crossref.org/works/10.1159%2F000091546

21 January 2018

Use of the Barthel index and modified Rankin scale in acute stroke trials.

1 reference

https://api.crossref.org/works/10.1159%2F000091546

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1159%2F000091546

21 January 2018

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1159%2F000091546

21 January 2018

Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia

1 reference

https://api.crossref.org/works/10.1159%2F000091546

21 January 2018

Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups

1 reference

https://api.crossref.org/works/10.1159%2F000091546

21 January 2018

Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke

1 reference

https://api.crossref.org/works/10.1159%2F000091546

21 January 2018

Identifiers

10.1159/000091546

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16490950

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48642231&oldid=2203829507"